Get Instant Stock Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
Eupraxia Pharmaceuticals Inc. (NASDAQ : EPRX) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product candidates address therapeutic areas with a high unmet medical need and strive to provide improved patient benefit by delivering targeted, long-lasting activity with fewer side effects. Its lead product candidate, EP-104IAR, is in development for the treatment of pain due to osteoarthritis of the knee. In addition, it is developing a pipeline of earlier-stage long-acting formulations.
Quote
| Last: | $6.84 |
|---|---|
| Change Percent: | 2.86% |
| Open: | $6.6 |
| Close: | $6.84 |
| High: | $6.86 |
| Low: | $6.52 |
| Volume: | 525,672 |
| Last Trade Date Time: | 11/06/2026 03:45:12 pm |
Stock Data
| Market Cap: | $435,556,805 |
|---|---|
| Float: | 34,844,532 |
| Insiders Ownership: | 4.18% |
| Institutions: | 8 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.eupraxiapharma.com |
| Country: | CA |
| City: | Victoria |
Chart & Financials
Recent News Releases
Subscribe to Our Newsletter
**MWN-AI FAQ is based on asking OpenAI questions about Eupraxia Pharmaceuticals Inc. (NASDAQ: EPRX).
